Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory bowel disease and carcinogenesis
Hiroko Nagao‐Kitamoto, Sho Kitamoto, Nobuhiko Kamada
Cancer and Metastasis Reviews (2022) Vol. 41, Iss. 2, pp. 301-316
Closed Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Gut inflammation and tumorigenesis: every site has a different tale to tell
Alessandro Vanoli, Paola Parente, Matteo Fassan, et al.
Internal and Emergency Medicine (2023) Vol. 18, Iss. 8, pp. 2169-2179
Open Access | Times Cited: 7
N6-methyladenosine-dependent signaling in colorectal cancer: Functions and clinical potential
Shaojun Liu, Min Liu, Yuxuan Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 198, pp. 104360-104360
Open Access | Times Cited: 2
Clostridioides difficile and colorectal cancer: a dangerous liaison
Gabrio Bassotti, Fabrizio Stracci, P Marconi, et al.
European Journal of Gastroenterology & Hepatology (2023) Vol. 35, Iss. 9, pp. 985-988
Closed Access | Times Cited: 4
ERCC4: a potential regulatory factor in inflammatory bowel disease and inflammation-associated colorectal cancer
Runjie Shi, Shanping Wang, Ying Jiang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Alkaline sphingomyelinase deficiency impairs intestinal mucosal barrier integrity and reduces antioxidant capacity in dextran sulfate sodium-induced colitis
Ye Tian, Xin Li, Xu Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 10, pp. 1405-1419
Open Access | Times Cited: 1
PIM1–HDAC2 axis modulates intestinal homeostasis through epigenetic modification
Jianming Yang, Yawen Xiao, Ningning Zhao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3049-3067
Open Access | Times Cited: 1
Dopamine β-hydroxylase shapes intestinal inflammation through modulating T cell activation
Qiaoling Sun, Heng Li, Jing Lv, et al.
Cellular Immunology (2024) Vol. 401-402, pp. 104839-104839
Closed Access | Times Cited: 1
Multispecies synbiotics alleviate dextran sulfate sodium (DSS)-induced colitis: Effects on clinical scores, intestinal pathology, and plasma biomarkers in male and female mice
Wenjie Cai, Kateryna Pierzynowska, Miranda Stiernborg, et al.
Clinical Nutrition ESPEN (2024) Vol. 63, pp. 74-83
Open Access | Times Cited: 1
Unraveling colorectal cancer prevention: The vitamin D - gut flora - immune system nexus
Zhi-Song Zhan, Zu-Shun Zheng, Jing Shi, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 6, pp. 2394-2403
Open Access | Times Cited: 1
Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer
Yang Zhang, Qianming Kang, Luying He, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Revisiting the relationship between complement and ulcerative colitis
Yujie Ma, Kaicheng Zhang, Yuanyuan Wu, et al.
Scandinavian Journal of Immunology (2023) Vol. 98, Iss. 5
Open Access | Times Cited: 3
Rosiglitazone Does Not Affect the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study in Taiwanese Type 2 Diabetes Patients
Chin‐Hsiao Tseng
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 679-679
Open Access | Times Cited: 3
Interleukin-34 deficiency aggravates development of colitis and colitis-associated cancer in mice
Zhao-Xiu Liu, Weijie Chen, Yang Wang, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 47, pp. 6752-6768
Open Access | Times Cited: 5
Transformation of colitis and colorectal cancer: a tale of gut microbiota
Kai Xia, Renyuan Gao, Lin Li, et al.
Critical Reviews in Microbiology (2023) Vol. 50, Iss. 5, pp. 653-662
Closed Access | Times Cited: 2
The Prokineticin System in Inflammatory Bowel Diseases: A Clinical and Preclinical Overview
Giada Amodeo, Silvia Franchi, Giulia Galimberti, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2985-2985
Open Access | Times Cited: 2
Special Issue: “Digestive Inflammation and New Therapeutical Targets”
Alain Couvineau, Cécile Haumaître
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4361-4361
Open Access
MiRNAs: a new target for Chinese medicine to repair the intestinal barrier in the treatment of ulcerative colitis
Dajuan Sun, Zhongtao Zhang, Jingwei Xue
Frontiers in Pharmacology (2024) Vol. 15
Open Access
The prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in colorectal cancer patients experiencing anastomotic leakage：a retrospective study
Nuo Xu, Zhuo Huang, Lian-Chun Mao, et al.
Research Square (Research Square) (2024)
Closed Access
miR-30c affects the pathogenesis of ulcerative colitis by regulating target gene VIP
Dong Xiang, Yuling Zhan, Minghui Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Immunomodulatory Role of Histamine in Oncoimmunology and Immunotherapy
Heba Shawky
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 351-390
Closed Access
Research Progress on the Effects of FXR on the Development of Colorectal Cancer
奕岑 钱
Hans Journal of Biomedicine (2024) Vol. 14, Iss. 04, pp. 608-615
Closed Access
Previous Page - Page 2

Scroll to top